46 related articles for article (PubMed ID: 38429657)
1. Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis.
Ward S; Scope A; Rafia R; Pandor A; Harnan S; Evans P; Wyld L
Health Technol Assess; 2013 Oct; 17(44):1-302. PubMed ID: 24088296
[TBL] [Abstract][Full Text] [Related]
2. Few-shot genes selection: subset of PAM50 genes for breast cancer subtypes classification.
Okimoto LYS; Mendonca-Neto R; Nakamura FG; Nakamura EF; Fenyö D; Silva CT
BMC Bioinformatics; 2024 Mar; 25(1):92. PubMed ID: 38429657
[TBL] [Abstract][Full Text] [Related]
3. Research-based PAM50 signature and long-term breast cancer survival.
Pu M; Messer K; Davies SR; Vickery TL; Pittman E; Parker BA; Ellis MJ; Flatt SW; Marinac CR; Nelson SH; Mardis ER; Pierce JP; Natarajan L
Breast Cancer Res Treat; 2020 Jan; 179(1):197-206. PubMed ID: 31542876
[TBL] [Abstract][Full Text] [Related]
4. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
[TBL] [Abstract][Full Text] [Related]
5. PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B.
Raj-Kumar PK; Liu J; Hooke JA; Kovatich AJ; Kvecher L; Shriver CD; Hu H
Sci Rep; 2019 May; 9(1):7956. PubMed ID: 31138829
[TBL] [Abstract][Full Text] [Related]
6. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
Wallden B; Storhoff J; Nielsen T; Dowidar N; Schaper C; Ferree S; Liu S; Leung S; Geiss G; Snider J; Vickery T; Davies SR; Mardis ER; Gnant M; Sestak I; Ellis MJ; Perou CM; Bernard PS; Parker JS
BMC Med Genomics; 2015 Aug; 8():54. PubMed ID: 26297356
[TBL] [Abstract][Full Text] [Related]
7. Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance.
Kim HK; Park KH; Kim Y; Park SE; Lee HS; Lim SW; Cho JH; Kim JY; Lee JE; Ahn JS; Im YH; Yu JH; Park YH
Cancer Res Treat; 2019 Apr; 51(2):737-747. PubMed ID: 30189722
[TBL] [Abstract][Full Text] [Related]
8. A Gene Selection Method Based on Outliers for Breast Cancer Subtype Classification.
Mendonca-Neto R; Li Z; Fenyo D; Silva CT; Nakamura FG; Nakamura EF
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(5):2547-2559. PubMed ID: 34860652
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Cancer Gene Expression Signatures: Current Status and Challenges.
Qian Y; Daza J; Itzel T; Betge J; Zhan T; Marmé F; Teufel A
Cells; 2021 Mar; 10(3):. PubMed ID: 33804045
[TBL] [Abstract][Full Text] [Related]
10. A Pipeline for Integrated Theory and Data-Driven Modeling of Biomedical Data.
Raghu VK; Ge X; Balajiee A; Shirer DJ; Das I; Benos PV; Chrysanthis PK
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(3):811-822. PubMed ID: 32841121
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omic Regulation of the PAM50 Gene Signature in Breast Cancer Molecular Subtypes.
Ochoa S; de Anda-Jáuregui G; Hernández-Lemus E
Front Oncol; 2020; 10():845. PubMed ID: 32528899
[TBL] [Abstract][Full Text] [Related]
12. Deep gene selection method to select genes from microarray datasets for cancer classification.
Alanni R; Hou J; Azzawi H; Xiang Y
BMC Bioinformatics; 2019 Nov; 20(1):608. PubMed ID: 31775613
[TBL] [Abstract][Full Text] [Related]
13. DeepCC: a novel deep learning-based framework for cancer molecular subtype classification.
Gao F; Wang W; Tan M; Zhu L; Zhang Y; Fessler E; Vermeulen L; Wang X
Oncogenesis; 2019 Aug; 8(9):44. PubMed ID: 31420533
[TBL] [Abstract][Full Text] [Related]
14. Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0).
Mi H; Muruganujan A; Huang X; Ebert D; Mills C; Guo X; Thomas PD
Nat Protoc; 2019 Mar; 14(3):703-721. PubMed ID: 30804569
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
